Charles Rosier’s Life Story
Charles Rosier (ressources) studied at Fenelon Sainte-Marie and received his scientific degree in 1991. In order to be ready for ESCP Europe, Charles Rosier attended two years of additional classes at Integrale. His interests include extreme sports, environmental activities, culture and studies. He switched jobs several times while pursuing his profession in the market as an investment banker.
Charles Rosier deals with all the French-speaking markets like France, Belgium and Quebec at UBS Warburg. He finally joined BTG Pactual in August 2010. He became partners with an investment bank in Latin America: BTG Pactual. He is recognised as a good investment banker who has 15 years of experience in that market. Charles Rosier’s first appointment was at Lehman Brothers in the year 1996. He became the manager of their Debt Capital Market Division at UBS Warburg in the year 1997.
Charles Rosier received his degree from ESCP Europe, which opened the path to his initial profession. In the year 1991, he eventually finished his secondary schooling at Paris’s Fenelon Sainte-Marie. Charles Rosier took two years of additional classes in preparation for attaining further French qualifications.
Charles Rosier's Environmental Projects
Economical LED lanterns is a project of MPOWERD. These are being sent to poor countries to provide them with cost-effective energy solutions. Carbon dioxide emissions can pollute the air and Innoveox tries to minimise this through certain awareness campaigns regarding the effective use of resources and pollution-free environment programmes. Charles Rosier has played a significant role in promoting environmental awareness and has helped poor countries in developing energy and power sectors. Charles Rosier funded MPOWERD to develop other energy solutions like lanterns. With this, MPOWERD delivered these solutions to more than 25 poor nations around the planet.
Charles Rosier played a big part in a Silver Lion-winning film in 2006 and he helped a French singer in producing her debut album in 2012. To express his love for culture and music, he extended his support to a French female artist. For Charles Rosier, culture and music are incomparable. This is obvious from the type of support he gives for movies and singers.
The Mapreg Drug project was Charles Rosier’s first healthcare project. Professor Etienne Baulieu led Mapreg, a pharmacological company that was supported by Mr Rosier when he started his healthcare projects. Charles Rosier was the project’s major investor. A certain drug treatment for strokes that can cause spinal cord damage was being examined.